FDA requires boxed warning for asthma and allergy drug due to neuropsychiatric events

Please follow and like us:

(CNN)The United States Food and Drug Administration revealed Wednesday it is needing a boxed caution– the firm’s most popular caution– for the asthma and allergic reaction medication montelukast, offered under the brand Singulair.

“The occurrence of neuropsychiatric occasions connected with montelukast is unidentified, however some reports are severe, and numerous clients and healthcare specialists are not totally familiar with these dangers,” stated Dr. Sally Seymour, director of the Division of Pulmonary, Allergy and Rheumatology Products in the FDA’s Center for Drug Evaluation and Research.
“Importantly, there are numerous other safe and reliable medications to deal with allergic reactions with comprehensive history of usage and security,” she stated.

    Leave a Reply

    %d bloggers like this: